INNOVATIVE LEADER IN

OCULAR THERAPY

Bright Science, Clear Vision

iVIEW Therapeutics is an ophthalmic pharmaceutical company committed to developing new therapies for clear vision and healthier lives. We are driven by the pursuit of innovative science that leads to differentiated products to fulfill unmet medical needs.

Differentiated Innovative Pipeline

Innovative Pipeline:

Sustainable Innovative Drug Development:

  • TRPM8 Technology
  • Target Based Small Molecule Discovery
  • Gene Therapy Development

NDDS Platform technology:

Innovative Drug Delivery Technology Platforms:

  • Innovative Drug Delivery Technology Platforms
  • Liposome technology platform

Target unmet medical needs:

Disease areas for significant unmet medical need:

  • Dry Eye
  • Myopia
  • Viral Conjunctivitis
  • Glaucoma Treatment
Image cant be loaded

CUTTING-EDGE
TECHNOLOGY

TRPM8 Agonist
Technology

LATEST UPDATES

2024-09-17

IVIEW Therapeutics Inc. Completes Patient Recruitment for Phase 1/2 Trial of IVW-1001 Ophthalmic Eyelid Wipe in Dry Eye Disease Patients

2024-06-25

IVIEW Therapeutics Inc. Announces Dosing of First Patient in Phase 1/2 Clinical Trial of IVW-1001 for Dry Eye Disease

Copyright © 2023 iVIEW Therapeutics, Inc. All rights reserved.

Terms of Use

Privacy Policy